Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2008-06-13
2010-06-08
Schnizer, Richard (Department: 1635)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C536S025300
Reexamination Certificate
active
07732593
ABSTRACT:
Based at least in part on an understanding of the mechanisms by which small RNAs (e.g., naturally-occurring miRNAs) mediate RNA silencing in plants, rules have been established for determining, for example, the degree of complementarity required between an RNAi-mediating agent and its target, i.e., whether mismatches are tolerated, the number of mismatches tolerated, the effect of the position of the mismatches, etc. Such rules are useful, in particular, in the design of improved RNAi-mediating agents which allow for more exact control of the efficacy of RNA silencing.
REFERENCES:
patent: 6506559 (2003-01-01), Fire et al.
patent: 7459547 (2008-12-01), Zamore et al.
patent: 2002/0086356 (2002-07-01), Tuschl et al.
patent: 2003/0108923 (2003-06-01), Tuschl et al.
patent: 2004/0002153 (2004-01-01), Monia et al.
patent: 2004/0137471 (2004-07-01), Vickers et al.
patent: 2004/0192629 (2004-09-01), Xu et al.
patent: 2004/0203145 (2004-10-01), Zamore et al.
patent: 2004/0224328 (2004-11-01), Prydz et al.
patent: 2004/0229266 (2004-11-01), Tuschl et al.
patent: 2004/0259247 (2004-12-01), Tuschl et al.
patent: 2004/0259248 (2004-12-01), Tuschl et al.
patent: 2005/0026278 (2005-02-01), Tuschl et al.
patent: 2005/0037988 (2005-02-01), Zamore et al.
patent: 2005/0059005 (2005-03-01), Tuschl et al.
patent: 2005/0181382 (2005-08-01), Zamore et al.
patent: 2005/0182005 (2005-08-01), Tuschl et al.
patent: 2005/0186586 (2005-08-01), Zamore et al.
patent: 2005/0227256 (2005-10-01), Hutvagner et al.
patent: 2005/0234007 (2005-10-01), Tuschl et al.
patent: 2005/0246794 (2005-11-01), Khvorova et al.
patent: 2005/0256072 (2005-11-01), Aronin et al.
patent: 2006/0009402 (2006-01-01), Zamore et al.
patent: 2006/0134787 (2006-06-01), Zamore et al.
patent: 2006/0166910 (2006-07-01), Tuschl et al.
patent: 2006/0212950 (2006-09-01), Tuschl et al.
patent: 2007/0003960 (2007-01-01), Tuschl et al.
patent: 2007/0003961 (2007-01-01), Tuschl et al.
patent: 2007/0003962 (2007-01-01), Tuschl et al.
patent: 2007/0003963 (2007-01-01), Tuschl et al.
patent: 2007/0031844 (2007-02-01), Khvorova et al.
patent: 2007/0039072 (2007-02-01), Khvorova et al.
patent: 2007/0093445 (2007-04-01), Tuschl et al.
patent: 2007/0207974 (2007-09-01), Khvorova et al.
patent: WO-01/75164 (2001-10-01), None
patent: WO 02/44321 (2002-06-01), None
patent: WO-03/020931 (2003-03-01), None
patent: WO-2004/027030 (2004-01-01), None
patent: WO-2004/045543 (2004-06-01), None
patent: WO-2004/063375 (2004-07-01), None
patent: WO-2005/001043 (2005-01-01), None
patent: WO-2005/062937 (2005-07-01), None
patent: WO-2006/015389 (2006-02-01), None
Elbashir et al (EMBO J. 20(23): 6877-6888, 2001).
Zeng et al (RNA 9: 112-123, 2003).
Xu et al (Virology 171(2): 331-341, 1989).
Elbashir et al (Nature 411: 494-498, 2001).
Haley et al (Nature Struct. & Mol. Biol 11(7): 599-606, 2004.
Amarzguioui, Mohammed et al., “Tolerance for mutations and chemical modifications in a siRNA,”Nucleic Acids Research, vol. 31(2):589-595 (2003).
Bartel, David P., “MicroRNAs: Genomics, Biogenesis, Mechanism, and Function,”Cell, vol. 116:281-297 (2004).
Beclin, Christophe et al., “A Branched Pathway for Transgene-Induced RNA Silencing in Plants,”Current Biology, vol. 12:684-688, (2002).
Boden, D. et al, “Efficient gene transfer of HIV-1-specific short hairpin RNA into human lymphocytic cells using recombinant adeno-associated virus vectors,”Mol. Ther., vol. 9(3):396-402 (2004).
Boden, Daniel et al, “Enhanced gene silencing of HIV-1 specific siRNA using microRNA designed hairpins,”Nucleic Acids Research, vol. 32(3):1154-1158 (2004).
Bonnet, Eric et al, “Evidence that microRNA precursors, unlike other non-coding RNAs, have lower folding free energies than random sequences,”Bioinformatics, vol. 20(17):2911-2917 (2004).
Chi, Jen-Tsan et al, “Genomewide view of gene silencing by small interfering RNAs,”PNAS, vol. 100(11):6343-6346 (2003).
Chiu, Ya-Lin et al, “RNAi in Human Cells: Basic Structural and Functional Features of Small Interfering RNA,”Molecular Cell, vol. 10:549-561 (2002).
Chiu, Ya-Lin et al, “siRNA function in RNAi: A chemical modification analysis,”RNA, vol. 9:1034-1048 (2003).
Cogoni, Carlo et al., “Gene silencing inNeurospora crassarequires a protein homologous to RNA-dependent RNA polymerase,”Nature. vol. 399:166-169. (1999).
Dalmay, Talmas et al., “An RNA-Dependent RNA Polymerase Gene inArabidopsisIs Required for Posttranscriptional Gene Silencing Mediated by a Transgene but Not by a Virus,”Cell. vol. 101:543-553, (2000).
Dharmacon RNA Technologies: On-Target siRNA, Company Brochure, 2003.
Dharmacon RNA Technologies: Products for RNA Interference, Company Brochure, 2003.
Doench, John G. et al, “siRNAs can function as miRNAs,”Genes&Development, vol. 17:438-442 (2003).
Du, Quan et al, “A sytematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites,”Nucleic Acids Research, vol. 33(5):1671-1677 (2005).
Elbashir, Sayda M. et al, “Analysis of gene function in somatic mammalian cells using small interfering RNAs,”Methods, vol. 26:199-213 (2002).
Elbashir, Sayda M. et al, “Functional anatomy of siRNAs for mediating efficient RNAi inDrosophila melanogasterembryo lysate,”The EMBO Journal, vol. 20(23):6877-6888 (2001).
Elbashir, Sayda M. et al, “RNA interference is mediated by 21- and 22-nucleotide RNAs,”Genes&Development, vol. 15:188-200 (2001).
Gong, Delquin et al, “Picking a winner: new mechanistic insights into the design of effective siRNAs,”Trends in Biotechnology, vol. 22(9):451-454 (2004).
Haley, Benjamin et al., “Kinetic analysis of the RNAi enzyme complex,”Nature Structural&Molecular Biology, vol. 11(7):599-606 (2004).
Haley, Benjamin et al, “In vitro analysis of RNA interference inDrosophila melanogaster,” Methods, vol. 30:330-336 (2003).
Hamada, Makiko et al, “Effects on RNA Interference in Gene Expression (RNAi) in Cultured Mammalian Cells of Mismatches and the Introduction of Chemical Modifications at the 3′-Ends of siRNAs,”Antisense and Nucleic Acid Drug Development, vol. 12:301-309 (2002).
Holen, Torgeir et al, “Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor,”Nucleic Acids Research, vol. 30(8):1757-1766 (2002).
Holen, Torgeir et al, “Similar behaviour of single-strand and double-strand siRNAs suggests they act through a common RNAi pathway,”Nucleic Acids Research, vol. 31(9):2401-2407 (2003).
Holen, Torgeir et al., “Tolerated wobble mutations in siRNAs decrease specificity, but can enhance activity in vivo,”Nucleic Acids Research, vol. 33(15):4707-4710 (2005).
Hutvágner, György et al, “A microRNA in a Multiple-Turnover RNAi Enzyme Complex,”Science, vol. 297:2056-2060 (2002).
Jackson, Aimee L. et al, “Expression profiling reveals off-target gene regulation by RNAi,”Nature Biotechnology, vol. 21(6):635-638 (2003).
Ketting, René F. et al, “Dicer functions in RNA interference and in synthesis of small RNA involved in development timing inC. elegans,” Genes&Development, vol. 15:2654-2659 (2001).
Khvorova, Anastasia et al, “Functional siRNAs and miRNAs Exhibit Strand Bias,”Cell, vol. 115:209-216 (2003).
Krol, Jacek et al, “Structural Features of MicroRNA (miRNA) Precursors and Their Relevance to miRNA Biogenesis and Small Interfering RNA/Short Hairpin RNA Design,”The Journal of Biological Chemistry, vol. 279(40):42230-42239 (2004).
Lagos-Quintana, Mariana et al., “Identification of Novel Genes Coding for Small Expressed RNAs,”Science.. vol. 294:853-858, (2001).
Lagos-Quintana, Mariana et al., “Identification of Tissue-Specific MicroRNAs from Mouse,”Current Biology. vol. 12:735-739, (2002).
Lai, Eric C., ȁ
Tang Guiliang
Zamore Phillip D.
Lahive & Cockfield LLP
Milasincic Esq. Debra J.
Schnizer Richard
University of Massachusetts
Velema, Esq. James H.
LandOfFree
Methods and compositions for controlling efficacy of RNA... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for controlling efficacy of RNA..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for controlling efficacy of RNA... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4212560